A "classic" shoe, like any timeless item in your wardrobe, should be a workhorse. It should work with a multitude of clothes you have, in more than one season. It should also be comfortable—both ...
Gravel shoes are now a well-established segment; long gone are the days of putting up with standard mountain bike shoes. Now most brands have some gravel-specific footwear in their range focusing ...
Whether you're looking to crush that marathon PB in 2025, put in more miles on the treadmill, or take up running for the first time in the New Year, then you need a pair of the best running shoes.
Having worn (and worn out) my fair share of sneakers, I set out to find the most comfortable walking shoes for men with the help of a panel of testers and a handful of experts. Among the 14 pairs ...
There are a LOT of running shoes on the market and each pair comes in all shapes and sizes offering all sorts of things from speed to agility to support to style. While it might be tempting to ...
If you're planning to get a lot of movement in, make sure your feet are supported with the best walking shoes. I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness ...
I have been using workout shoes for as long as I can remember, and those shoes have evolved over the years from the pair of beat-up Nikes I wore in high school to the Asics and Converses I had for ...
Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...
Rapper Snoop Dogg is showing his support for President-elect Trump. The "Gin and Juice" rapper took the stage at the Crypto Ball, a pre-inauguration event, and got the crowd on its feet dancing to ...
It’s ordinary people, and not superheroes, who bring about justice and change in the real world. In “Lilly,” writer-director Rachel Feldman follows the era-defining work of one such everyday ...
The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025. In this ...
Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market. Lilly’s ...